Which are considered key items the FDA will contemplate when deciding on whether REMS is needed?

Which are considered key items the FDA will contemplate when deciding on whether REMS is needed?

• A. Seriousness of the disease
• B. Seriousness of side effects
• C. Benefit of the drug
• D. All of the above

Answer: (D)

REMS decisions hinge on the balance of risk and benefit for a drug. The FDA considers how serious the disease is that the drug treats, how severe or likely the potential adverse effects are, and the overall benefit the drug provides, including how meaningful its clinical effect is. When a disease is serious or life-threatening, the drug offers substantial benefit, and there are notable safety concerns that could be mitigated with specific risk-management measures, the agency is more likely to require a REMS. Taken together, these factors determine whether additional controls are needed to ensure safe use, so all three items are part of the consideration.

REMS decisions hinge on the balance of risk and benefit for a drug. The FDA considers how serious the disease is that the drug treats, how severe or likely the potential adverse effects are, and the overall benefit the drug provides, including how meaningful its clinical effect is. When a disease is serious or life-threatening, the drug offers substantial benefit, and there are notable safety concerns that could be mitigated with specific risk-management measures, the agency is more likely to require a REMS. Taken together, these factors determine whether additional controls are needed to ensure safe use, so all three items are part of the consideration.